Summary
Thermo Fisher Scientific Inc. reported strong revenue growth for the third quarter and first nine months of 2007, largely driven by the significant merger with Fisher Scientific International Inc. completed in late 2006. Consolidated revenues for the third quarter reached $2.40 billion, a substantial increase from $724.9 million in the prior year's comparable quarter. For the nine-month period, revenues climbed to $7.13 billion from $2.12 billion in the same period last year. While operating income saw a significant increase to $254 million in Q3 2007 from $75 million in Q3 2006, the operating margin remained relatively stable year-over-year. The company experienced a notable decrease in its effective tax rate to 7.1% in Q3 2007, significantly benefiting from a one-time tax credit related to enacted reductions in tax rates in the UK, Denmark, and Germany. This, combined with higher operating income, led to a substantial increase in net income from $48.8 million in Q3 2006 to $218.5 million in Q3 2007.
Key Highlights
- 1Revenue growth was substantial, driven by the Fisher Scientific merger, with Q3 2007 revenues at $2.40 billion and nine-month revenues at $7.13 billion.
- 2Operating income increased significantly to $254 million in Q3 2007 from $75 million in Q3 2006.
- 3Net income rose sharply from $48.8 million in Q3 2006 to $218.5 million in Q3 2007, aided by a favorable tax rate.
- 4The effective tax rate decreased significantly to 7.1% in Q3 2007 due to one-time benefits from international tax rate reductions.
- 5The company completed several strategic acquisitions in 2007, including Spectronex AG, Flux AG, and the instrument sales business of Davis Inotek Instruments, LLC, to broaden its offerings.
- 6Cash flow from operations saw a significant increase to $948 million for the first nine months of 2007, up from $200 million in the prior year.
- 7The company is actively repurchasing its common stock, with $460 million remaining under its authorized repurchase program as of September 29, 2007.